GO
Loading...

European Stocks to Watch: Novartis

Swiss drug maker Novartis was the only gainer on Zurich's SMI index Wednesday, rising 0.2%, after an American federal court extended a temporary restraining order blocking a generic version of the pharmaceutical's high-blood-pressure drug Lotrel.

Copies of the Novartis drug, made by Israel-based Teva Pharmaceutical were halted, apart from shipments already on the way to customers.

The move is a boost for the major pharmaceutical companies, which have come under increasing pressure from generic competition in recent years.

Eurotunnel (Up 56%) Shares in the cross-channel train operator continued to soar for a second day following positive reaction to its public share swap offer Tuesday, which effectively re-floated the company with newly issued shares after a week-long suspension.

Air Berlin (Down 5.3%) Ulf Huettmeyer, finance chief of the German carrier, said he is expecting an earnings before interest and tax (EBIT) margin of about 6% for the full year, which is at the low end of its previous target of 6-7%, when speaking on a conference call.

LogicaCMG (Up 3.9%) Following the announcement that Chief Executive Martin Read is to step down from the London listed IT company, speculation is mounting about a possible takeover from private equity firm Permira.

EADS (Down 1.3%) Shares in the owner of Airbus declined as the plane maker said it was to boost jobs outsourcing to 50%, from a current 20-25%, the managing director of its U.K. unit told Reuters.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • Expect financials to 'perk up': Pro

    David Katz, Matrix Asset Advisor CEO, provides his outlook on the markets and explains why he is not giving up on IBM.

  • IBM reports mixed results

    Sherri Scribner, Deutsche Bank Research, weighs in on Big Blues' quarterly numbers of $2.91 Adj. EPS on revenues of $19.59 billion. Also Scribner provides perspective on the tech giant's cloud growth and new products.

  • Wall Street seeks to extend rebound

    With the flood of earnings continuing today, stocks look to add to Monday's rally that saw the major averages chalk up their best gains of April.